Management of Recurrent Uncomplicated Urinary Tract Infections in Women of Reproductive Age

Initial Evaluation and Risk‑Factor Assessment

• The American College of Radiology advises that routine imaging is not required for women with recurrent uncomplicated UTIs, because the vast majority have normal urinary tracts. 1
• Modifiable behavioral risk factors that increase recurrence should be assessed in premenopausal women, including patterns of sexual activity (frequency and temporal relationship to symptoms). 2

Indications for Imaging

• Imaging should be reserved for cases that meet any of the following criteria: rapid recurrence within 2 weeks of treatment, relapse with the same organism despite therapy, failure of symptoms to resolve within 7 days of appropriate antibiotics, or clinical suspicion of a structural abnormality (e.g., palpable bladder, incontinence, prior surgery). 1
• When imaging is indicated, CT urography or MR urography is recommended to evaluate for urinary calculi, foreign bodies, urethral/bladder diverticula, infected urachal cysts, or postoperative changes. 1

Acute Episode Treatment

• Nitrofurantoin 100 mg taken twice daily for 5 days is the first‑line oral therapy for each acute episode, demonstrating a low baseline resistance rate (~2.6 %) compared with ciprofloxacin (≈ 83.8 %) and trimethoprim (≈ 78.3 %). 2
• A urine culture should be obtained for every recurrent episode to confirm the pathogen and guide subsequent therapy. 2

Prevention Strategies

Behavioral and Non‑Antimicrobial Interventions (First‑Line)

• Increase daily fluid intake to dilute urine and reduce bacterial colonisation. 2
• Encourage post‑coital voiding immediately after intercourse. 2
• Discontinue spermicide‑containing contraceptives and switch to alternative methods. 2
• Recommend cranberry tablets (rather than juice) as a prophylactic supplement. 2
• Offer non‑antibiotic agents such as D‑mannose or methenamine hippurate. 2
• Suggest lactobacillus‑containing probiotics to support normal vaginal flora. 2

Antimicrobial Prophylaxis (After Failure of Non‑Antibiotic Measures)

• Post‑coital prophylaxis: a single dose of an appropriate antibiotic taken after intercourse for women whose UTIs are clearly linked to sexual activity. 2
• Continuous daily prophylaxis: nitrofurantoin 50 mg at bedtime for up to 12 months for women with UTIs unrelated to sexual activity; the lower dose maintains efficacy while improving safety. 2
• Patient‑initiated self‑start therapy: at the first sign of symptoms, the patient begins nitrofurantoin 100 mg twice daily for 5 days while a urine culture is obtained; this requires reliable patient adherence. 2

Key Pitfalls

• Do not treat asymptomatic bacteriuria, as it does not prevent symptomatic infections and promotes resistance.
• Avoid broad‑spectrum agents (e.g., fluoroquinolones, cephalosporins) when nitrofurantoin is appropriate, to preserve protective vaginal and periurethral microbiota.
• Reserve imaging for the specific scenarios outlined above; routine imaging offers no benefit in uncomplicated recurrent cases. 1

Recurrent Urinary Tract Infections

Microbiological Causes

• The American College of Radiology suggests that Escherichia coli is the causative organism in approximately 75% of recurrent UTIs across all patient groups 3
• Other common organisms include Enterococcus faecalis, Proteus mirabilis, Klebsiella species, and Staphylococcus saprophyticus (particularly in patients with risk factors for complicated UTIs) 3
• In complicated UTIs, the microbial spectrum expands significantly with greater antimicrobial resistance, and common organisms include E. coli, Proteus spp., Klebsiella spp., Pseudomonas spp., Serratia spp., and Enterococcus spp. 4, 5

Mechanisms of Recurrence

• Reinfection is the most common mechanism, defined as infection developing >2 weeks after symptomatic cure or caused by a second pathogen 3
• Relapse/Persistent infection is characterized by chronic infections with the same organism, or recurrence within 2 weeks of initial treatment 3
• Bacterial persistence factors, such as urinary calculi, foreign bodies, urethral or bladder diverticula, infected urachal cyst, and postoperative changes, should be considered when infections recur rapidly (within 2 weeks) 3

Host-Related Risk Factors

• The American College of Radiology recommends that patients with recurrent UTIs should be evaluated for host-related risk factors, including use of spermicidal-containing contraceptives, inadequate hydration, infrequent voiding, and lack of post-coital voiding 3, 6
• Anatomical abnormalities, such as urinary tract obstruction, cystocele, bladder or urethral diverticula, vesicoureteral reflux, incomplete voiding, and fistulae, increase the risk of recurrent UTIs 3, 4, 5, 6
• Postmenopausal women with recurrent UTIs should be evaluated for atrophic vaginitis and urinary incontinence 3, 6
• Medical comorbidities, such as diabetes mellitus, immunosuppression, pregnancy, history of urinary tract instrumentation, and indwelling catheters, increase the risk of recurrent UTIs 4, 5

Clinical Pitfalls to Avoid

• Imaging is of low yield in patients without underlying risk factors, with less than two episodes per year, who respond promptly to appropriate therapy, according to current guidelines 3
• However, patients with bacterial cystitis recurring rapidly (within 2 weeks of initial treatment) or displaying bacterial persistence without symptom resolution should be reclassified as complicated and require imaging to detect treatable structural conditions 3